Notice of Change to PAR-18-437 "Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)"

Notice Number: NOT-DA-19-042

Key Dates
Release Date: May 29, 2019

Related Announcements
PAR-18-437

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of the Notice is to change the Key Dates in PAR-18-437 "Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)".

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; December 20, 2019; August 20, 2020; and December 18, 2020

AIDS Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; December 20, 2019; August 20, 2020; and December 18, 2020

Scientific Merit Review: November 2018; March 2019; November 2019; March 2020; November 2020; and March 2021

Advisory Council Review: January 2019; May 2019; January 2020; May 2020; January 2021; and May 2021

Earliest Start Date: April 1, 2019; July 1, 2019; April 1, 2020; July 1, 2020; April 1, 2021; and July 1, 2021

Expiration Date: December 19, 2020

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; February 10, 2020, August 20, 2020; and February 10, 2021

AIDS Application Due Date(s): August 20, 2018; December 20, 2018; August 20, 2019; February 10, 2020, August 20, 2020; and February 10, 2021

Scientific Merit Review: November 2018; March 2019; November 2019; May 2020 ; November 2020; and May 2021

Advisory Council Review: January 2019; May 2019; January 2020; October 2020; January 2021; and October 2021

Earliest Start Date: April 1, 2019; July 1, 2019; April 1, 2020; August 1, 2020 ; April 1, 2021; and August 1, 2021

Expiration Date: February 11, 2021

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Amy C. Lossie, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6092
Email:lossieac@mail.nih.gov